Search in:

Acta Orthopaedica Volume 86, 2015 - Issue 5

Journal homepage

Open access

951

Views

CrossRef citations to date

Altmetric

Original Articles

No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty

A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial

Olle MurenDivision of Orthopedics, Department of Clinical Sciences, Danderyd Hospital and the Karolinska Institute, Stockholm, SwedenCorrespondence[email protected]

Ehsan AkbarianDivision of Orthopedics, Department of Clinical Sciences, Danderyd Hospital and the Karolinska Institute, Stockholm, SwedenCorrespondence[email protected]

Mats SalemyrDivision of Orthopedics, Department of Clinical Sciences, Danderyd Hospital and the Karolinska Institute, Stockholm, SwedenCorrespondence[email protected]

Henrik BodénDivision of Orthopedics, Department of Clinical Sciences, Danderyd Hospital and the Karolinska Institute, Stockholm, SwedenCorrespondence[email protected]

Thomas EislerDivision of Orthopedics, Department of Clinical Sciences, Danderyd Hospital and the Karolinska Institute, Stockholm, SwedenCorrespondence[email protected]

André StarkDivision of Orthopedics, Department of Clinical Sciences, Danderyd Hospital and the Karolinska Institute, Stockholm, SwedenCorrespondence[email protected]

Olof SköldenbergDivision of Orthopedics, Department of Clinical Sciences, Danderyd Hospital and the Karolinska Institute, Stockholm, SwedenCorrespondence[email protected]

show all

Pages 569-574 | Received 16 Sep 2014, Accepted 14 Mar 2015, Published online: 01 Sep 2015

Cite this article
https://doi.org/10.3109/17453674.2015.1041846
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (24)

Joseph SerinoIIIIII, E. Bailey Terhune, William Harkin, Matthew T. Weintraub, Sanford Baim & Craig J. Della Valle. (2023) Bisphosphonate Use may be Associated with an Increased Risk of Periprosthetic Hip Fracture. The Journal of Arthroplasty.
Crossref

T. David Tarity, William Xiang, Paul Guirguis, Elizabeth B. Gausden, Brian P. Chalmers, Friedrich Boettner, Alberto V. Carli & Peter K. Sculco. (2023) Early Femoral Insufficiency Fractures After Primary Total Knee Arthroplasty. Arthroplasty Today 20, pages 101110.
Crossref

M. M. Kai Huang, M. M. Gang Wang & M. D. Yi Zeng. (2022) Comment on “The efficiency of risedronate in reducing bone resorption after total hip arthroplasty: a meta-analysis of randomized control trials at a minimum of 6 months’ follow-up”. Journal of Orthopaedic Surgery and Research 17:1.
Crossref

Kai Huang, Gang Wang & Yi Zeng. (2022) Letter to the Editor: Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty: a meta-analysis. Journal of Orthopaedic Surgery and Research 17:1.
Crossref

Allen Herng Shouh Hsu, Chun-Hsien Yen, Feng-Chih Kuo, Cheng-Ta Wu, Tsan-Wen Huang, Juei-Tang Cheng & Mel S. Lee. (2022) Zoledronic Acid Ameliorates the Bone Turnover Activity and Periprosthetic Bone Preservation in Cementless Total Hip Arthroplasty. Pharmaceuticals 15:4, pages 420.
Crossref

Jianda Xu, Huan Li, Yuxing Qu, Chong Zheng, Bin Wang, Pengfei Shen, Zikang Xie, Kang Wei, Yan Wang & Jianning Zhao. (2021) Denosumab might prevent periprosthetic bone loss after total hip and knee arthroplasties: a review. Arthroplasty 3:1.
Crossref

Jukka Kiuttu, Petri Lehenkari, Hannu-Ville Leskelä, Olli Yrjämä, Pasi Ohtonen & Maarit Valkealahti. (2021) Intra-operative Clodronate Rinsing Improves the Integration of the Femoral Stem in a Prospective, Double-blinded, Randomized, Placebo-controlled Clinical RSA-study. The Open Orthopaedics Journal 15:1, pages 1-12.
Crossref

Xi Chen, Yu Shen, Chenyi Ye, Yishake Mumingjiang, Jinwei Lu & Yunxian Yu. (2021) Prophylactic efficacy on periprosthetic bone loss in calcar region after total hip arthroplasty of antiosteoporotic drugs: a network meta-analysis of randomised controlled studies. Postgraduate Medical Journal 97:1145, pages 150-155.
Crossref

Se-Won LeeWeon-Yoo KimJoo-Hyoun SongJae-Hoon KimHwan-Hee Lee. (2021) Factors Affecting Periprosthetic Bone Loss after Hip Arthroplasty. Hip & Pelvis 33:2, pages 53.
Crossref

Mohammed Mahri, Nicole Shen, Francisco Berrizbeitia, Rania Rodan, Ammar Daer, Matthew Faigan, Doaa Taqi, Kevin Yang Wu, Motahareh Ahmadi, Maxime Ducret, Elham Emami & Faleh Tamimi. (2021) Osseointegration Pharmacology: A Systematic Mapping Using Artificial Intelligence. Acta Biomaterialia 119, pages 284-302.
Crossref

Long Gong, Yao‐yao Zhang, Na Yang, Huan‐juan Qian, Ling‐kun Zhang & Ming‐sheng Tan. (2020) Raloxifene Prevents Early Periprosthetic Bone Loss for Postmenopausal Women after Uncemented Total Hip Arthroplasty: A Randomized Placebo‐Controlled Clinical Trial. Orthopaedic Surgery 12:4, pages 1074-1083.
Crossref

Sravya P. Vajapey, Jesse Morris, Dan Li, Nicholas G. Greco, Mengnai Li & Andrew I. Spitzer. (2020) Outcome Reporting Patterns in Total Hip Arthroplasty. JBJS Reviews 8:4, pages e0197-e0197.
Crossref

Andreas Nyström, Demostenis Kiritopoulos, Gösta Ullmark, Jens Sörensen, Marianne Petrén‐Mallmin, Jan Milbrink, Nils P Hailer & Hans Mallmin. (2019) Denosumab Prevents Early Periprosthetic Bone Loss After Uncemented Total Hip Arthroplasty: Results from a Randomized Placebo‐Controlled Clinical Trial. Journal of Bone and Mineral Research 35:2, pages 239-247.
Crossref

Young-Kyun Lee, Tae-Young Kim, Yong-Chan Ha & Kyung-Hoi Koo. (2019) To withhold or to implement bisphosphonate after cementless hip arthroplasty: a dilemma in elderly hip fracture patients. Journal of Orthopaedic Surgery and Research 14:1.
Crossref

Xiang-Dong Wu, Mian Tian, Yao He, Hong Chen, Yu Chen, Rahul Mishra, Wei Liu & Wei Huang. (2019) Short to Midterm Follow-Up of Periprosthetic Bone Mineral Density after Total Hip Arthroplasty with the Ribbed Anatomic Stem. BioMed Research International 2019, pages 1-11.
Crossref

Jialing Shi, Guang Liang, Rongzhi Huang, Liang Liao & Danlu Qin. (2018) Effects of bisphosphonates in preventing periprosthetic bone loss following total hip arthroplasty: a systematic review and meta-analysis. Journal of Orthopaedic Surgery and Research 13:1.
Crossref

Liqing Yang. (2018) The efficiency of risedronate in reducing bone resorption after total hip arthroplasty: a meta-analysis of randomized control trials at a minimum of 6 months’ follow-up. Journal of Orthopaedic Surgery and Research 13:1.
Crossref

Qifeng Li & Baoshan Xu. (2018) Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty: a meta-analysis. Journal of Orthopaedic Surgery and Research 13:1.
Crossref

Jing Su, Yi Wei, Xiao Ming Li, Yan-Ping Diao, Huai-Gang Liu & Liang Zhang. (2018) Efficacy of risedronate in improving bone mineral density in patients undergoing total hip arthroplasty. Medicine 97:51, pages e13346.
Crossref

M. Shi, L. Chen, Z. Xin, Y. Wang, W. Wang & S. Yan. (2018) Bisphosphonates for the preservation of periprosthetic bone mineral density after total joint arthroplasty: a meta-analysis of 25 randomized controlled trials. Osteoporosis International 29:7, pages 1525-1537.
Crossref

Erik Aro, Niko Moritz, Kimmo Mattila & Hannu T. Aro. (2018) A long-lasting bisphosphonate partially protects periprosthetic bone, but does not enhance initial stability of uncemented femoral stems: A randomized placebo-controlled trial of women undergoing total hip arthroplasty. Journal of Biomechanics 75, pages 35-45.
Crossref

Liang Ren & Weidong Wang. (2018) Effect of risedronate on femoral periprosthetic bone loss following total hip replacement. Medicine 97:17, pages e0379.
Crossref

Meng Wang, Liang Wang & Ruqing Ye. (2018) Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty: A systematic review and meta-analysis. International Journal of Surgery 52, pages 189-200.
Crossref

Hidemi Kawaji, Takuya Uematsu, Ryosuke Oba, Naoya Hoshikawa, Hiroshi Watanabe & Shinro Takai. (2016) Influence of Femoral Implant Alignment in Uncemented Total Hip Replacement Arthroplasty: Varus Insertion and Stress Shielding. Journal of Nippon Medical School 83:6, pages 223-227.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty

A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial

Articles from other publishers (24)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty

A 4-year follow-up of 61 patients in a double-blind, randomized placebo-controlled trial

Citations (24)

Articles from other publishers (24)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date